Cleerly
Focus: Cleerly is an AI-driven medical imaging analytics company focused on coronary artery disease assessment using advanced CT analysis. The company operates in the cardiovascular biotechnology space with a clinical-stage technology platform.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Open Jobs
14-5 this month
Cooling — net -5 jobs in 30d
7 added, 12 removed. Slower than typical.
Should You Work at Cleerly?
AI assessmentCleerly is a high-risk, high-reward early-stage opportunity best suited for professionals comfortable with venture-backed uncertainty who want to shape a digital-first cardiovascular platform at commercial launch.
Why Work Here
- Cutting-edge AI application in high-unmet-need cardiovascular space with multiple active clinical registries demonstrating real-world evidence generation.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT07460583ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
N/AHelp build intelligence for Cleerly
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.